Support Alzheimer research foundation
The Dassault Group supports Alzheimer research foundation
The Dassault Group has participated in the acquisition of a PET-MRI scanner – a hybrid imaging technology using Positron Emission Topography (PET) and Magnetic Resonance Imaging (MRI) – installed in 2015 in the services section of La Pitié Salpétrière hospital in Paris (13th arrondissement). The installation of this scanner will serve two aims: to improve the care of Alzheimer patients, and to advance research on the disease.
The Alzheimer Research Foundation is a non-profit organisation whose goal is to help advance research and knowledge of Alzheimer's disease. Its research projects are funded solely through private donations, and Serge Dassault, Chairman of the Dassault Group, wished to support research in this field.
It has become urgent to support the cause and to improve our knowledge of the development of this disease because the rise in the elderly population and increased life expectancy mean that the number of those affected by the disease is growing exponentially. With the need for treatment steadily progressing due to this new demographic profile, the way in which patients are cared for must also evolve.
As a community of doctors and researchers specialising in the neurosciences, the Foundation's goal is to better understand Alzheimer's and related diseases in order to diagnose and treat these diseases as early as possible. The PET-MRI – an especially innovative imaging machine that is for the moment still rarely found in the hospital sector – can be used to improve the clinical care of Alzheimer's patients, as well as other neurocerebral disorders such as Parkinson's disease, epilepsy and multiple sclerosis. It is also an important tool for developing research on Alzheimer's disease and other forms of cerebral degeneration.
To contribute to improving care and advancing research, on 18 July 2014, Serge Dassault – in the presence of Professor Didier Dormont, head of the imaging service of La Pitié-Salpêtrière hospital; Professor Philippe Grenier, Chairman of the medical commission of La Pitié-Salpêtrière; Mr. Serge Morel, Director of La Pitié-Salpêtrière; Mr. Olivier de Ladoucette, Chairman of the Alzheimer Research Foundation; and Professor Bruno Dubois, Chairman of the Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) at La Pitié-Salpêtrière – presented the Foundation with a cheque for 2 million euros. This donation has financed 50% of the acquisition cost of the scanner.